From myelin debris to inflammatory responses: A vicious circle in diffuse axonal injury

Medical Hypotheses

Volumn 77, Issue 1, 2011, Pages 60-62

  Yang, X F ^a   Wang, H ^a   Wen, L ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 2; MYELIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DIFFUSE AXONAL INJURY; DISEASE MARKER; IMMUNE RESPONSE; INFLAMMATION; PROTEIN EXPRESSION; UPREGULATION;

AXONS; CYTOKINES; HUMANS; INFLAMMATION; MYELIN SHEATH;

EID: 79958060139     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.03.023     Document Type: Article

References (25)

1. Büki A., Povlishock J.T. All roads lead to disconnection? - Traumatic axonal injury revisited. Acta Neurochir (Wien) 2006, 148:181-194.
2. Adams J.H., Graham D.I., Murray L.S., Scott G. Diffuse axonal injury due to nonmissile head injury in humans: an analysis of 45 cases. Ann Neurol 1982, 12(6):557-563.
3. Pettus E.H., Povlishock J.T. Characterization of a distinct set of intra-axonal ultrastructural changes associated with traumatically induced alteration in axolemmal permeability. Brain Res 1996, 722(1-2):1-11.
4. Buki A., Siman R., Trojanowski J.Q., Povlishock J.T. The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury. J Neuropathol Exp Neurol 1999, 58(4):365-375.
5. Buki A., Okonkwo D.O., Wang K.K., Povlishock J.T. Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci 2000, 20(8):2825-2834.
6. Kelley B.J., Lifshitz J., Povlishock J.T. Neuroinflammatory responses after experimental diffuse traumatic brain injury. J Neuropathol Exp Neurol 2007, 66(11):989-1001.
7. Sun Xin, Wang Xi, Chen Tianxiang, Li Tianyi, Cao Kai, Lu Andrew, et al. Myelin activates FAK/Akt/NF-kB pathways and provokes CR3-dependent inflammatory response in murine system. PLoS ONE 2010, 5(2):e9380.
8. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000, 403:434-439.
9. McKerracher L., David S., Jackson D.L., Kottis V., Dunn R.J., et al. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 1994, 13:805-811.
10. Whitney N.P., Eidem T.M., Peng H., Huang Y.L., Zheng J.C. Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders. J Neurochem 2009, 108:1343-1359.
11. Kadhim H.J., Duchateau J., Sebire G. Cytokines and brain injury: invited review. J Intensive Care Med 2008, 23(5):236-249.
12. Saatman K.E., Creed J., Raghupathit R. Calpain as a therapeutic target in traumatic brain injury. Neurotherapeutics 2010, 7(1):31-42.
13. Haldcr R.C., Jahng A., Maricic I., Kumar V. Mini review: immune response to myelin-derived sulfatide and CNS-demyelinating. Neurochem Res 2007, 32:257-262.
14. Jeon S.B., Yoon H.J., Park S.H., Kim I.H., Park E.J. Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells. J Immunol 2008, 181(11):8077-8087.
15. Johns T.G., Bernard C.C. Binding of complement component Clq to myelin oligodendrocyte glycoprotein: a novel mechanism for regulating CNS inflammation. Mol Immunol 1997, 34(1):33-38.
16. Esther C., Volkmar H.I., Emerita A., Otmar T., Thomas K., Maria C.M. Cell activation and inflammatory response following traumatic axonal injury in the rat. Clin Neurosci 2000, 11(8):2587-2590.
17. Shohami E., Ginis I., Hallenbeck J.M. Dual role of tumor necrosis alpha in brain injury. Cytokine Growth Factor Rev 1999, 10:119-130.
18. Feuerstein G.Z., Wang X., Barone F.C. The role of cytokines in the neuropathology of stroke and neurotrauma. Neuroimmunomodulation 1998, 5(3-4):143-159.
19. Marmarou A., Foda M.A., van den Brink W., Campbell J., Kita H., Demetriadou K. A new model of diffuse brain injury in rats. Part I: pathophysiology and biomechanics. J Neurosurg 1994, 80(2):291-300.
20. Chung R.S., Staal J.A., McCormack G.H., Dickson T.C., Cozens M.A., Chuckowree J.A., et al. Mild axonal stretch injury in vitro induces a progressive series of neurofilament alterations ultimately leading to delayed axotomy. J Neurotrauma 2005, 22(10):1081-1091.
21. Murphy M., Reid K., Hilton D.J., Bartlett P.F. Generation of sensory neurons is stimulated by leukemia inhibitory factor. Proc Natl Acad Sci USA 1991, 88(8):3498-3501.
22. Hendriks J.J., Slaets H., Carmans S., de Vries H.E., Dijkstra C.D., Stinissen P., et al. Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. J Neuroimmunol 2008, 204(1-2):52-57.
23. Griffin J.W., George R., Lobato C., Tyor W.R., Yan L.C., Glass J.D. Macrophage responses and myelin clearance during Wallerian degeneration: relevance to immune-mediated demyelination. J Neuroimmunol 1992, 40(2-3):153-165.
24. George R., Griffin J.W. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model. Exp Neurol 1994, 129(2):225-236.
25. Vargas M.E., Barres B.A. Why is Wallerian degeneration in the CNS so slow?. Annu Rev Neurosci 2007, 30:153-179.